Overview

Vivodyne develops advanced human tissue models and related platforms for drug discovery. Its approach combines human tissue engineering, scalable robotics, and AI models to create preclinical systems that allow testing of drug efficacy before clinical trials. By offering these tissue models and associated services to pharmaceutical and biotech customers, Vivodyne helps researchers obtain preclinical certainty, speed up development, and reduce costs. The company differentiates itself by integrating tissue engineering with robotics and AI at scale to produce human-specific models instead of relying on traditional animal or non-human data. The goal is to improve predictability in early drug development, shorten timelines, and increase the likelihood of clinical success for therapeutic candidates.